Genomind

03/18/2026

Are you tired of the rollercoaster ride called finding the right medication(s)?

Finding the right medication(s) should not be a trial-and-error process. Our PGx test can help you and your provider understand how your genes may influence your response to medications so you can get to a more effective, personalized treatment the first time.

Get greater clarity about how your body responds to medications and have more confidence in your care. Get tested today: https://genomind.com/solutions/genomind-pgx-test/

Genomind’s PGx test analyzes your DNA and identifies medications (both prescription and over-the-counter) better suited for you.

03/11/2026

Analysis of 38 genes. 7 in-depth reports full of insights into your 7 Genetic Determinants of Health (GDOH). And a whole lot of clarity about your whole body health.

That's what our MentalHealthMap™ test gets you. With just a 30-second cheek swab, you can create a personalized wellness plan tailored to your genes.

Bring genetics-based clarity into your wellness routine. Get a MentalHealthMap™ test today: https://mentalhealthmap.com/

03/05/2026

Genomind’s PGx test offers actionable, genetics-based insights that can help guide medication discussions between patients and their providers.

By understanding how genetic differences may influence medication response, those conversations can become more focused and personalized. Instead of navigating treatment through trial-and-error alone, patients and clinicians can approach decisions with greater clarity and confidence.

Take the next step toward more personalized care and more productive conversations with your provider. Learn more about Genomind’s PGx testing today: https://genomind.com/solutions/genomind-pgx-test/

02/23/2026

After years, Leslie was no longer "shooting in the dark with medications" thanks to our PGx test. With the results, she and her provider found more targeted medication choices that help Leslie feel better than she has had in years.

You can get the same genetics-informed insights to help you and your provider find medications that work for your body.

Ready to finally have medications that work as well as they should? Get tested today: https://genomind.com/solutions/genomind-pgx-test/

02/12/2026

Better, more informed conversations lead to better care.

Genomind's PGx test analyzes 26 genes and over 1,200 medications—revealing how your body metabolizes drugs and identifying gene-drug, drug-drug, and drug-gene interactions. With the power of PGx, patients benefit from an increased level of precision and efficiency in tailored care.

When both patients and providers have clearer information, the path forward becomes stronger. Get tested today: https://genomind.com/getstarted/

02/05/2026

Find answers about your health through your DNA with MentalHealthMap™. Get started today: https://genomind.com/solutions/mental-health-map/

02/03/2026

A new JAMA Psychiatry study (https://www.einpresswire.com/article/887081756/new-jama-psychiatry-study-estimates-366-8-billion-annual-cost-of-schizophrenia-with-state-by-state-breakdown) estimates the annual "total societal cost" of schizophrenia in the U.S. at $366.8 billion. One factor that contributes to this number is the high cost of trial-and-error treatment. Too often, patients and providers spend months or years finding medications that work.

Our PGx test helps bring clarity by showing how a patient's genes may influence medication response, supporting more informed and personalized treatments. By reducing guesswork, PGx testing has the potential to improve outcomes and ease both personal and system-wide burden.

Learn how Genomind’s PGx test can help guide smarter medication decision. Get started today: https://genomind.com/solutions/genomind-pgx-test/

Genomind’s PGx test analyzes your DNA and identifies medications (both prescription and over-the-counter) better suited for you.

01/29/2026

We're proud to share that Genomind has been awarded a contract by the U.S. Department of Defense to provide pharmacogenomics consulting in support of the Defense Health Agency.

This work will help guide the assessment and implementation of PGx within the Department of Defense Military Health System, with the goal of optimizing medication management and reducing adverse drug reactions and other health complications.

It’s an important step in advancing PGx and in supporting the health and readiness of those who serve.

https://www.businesswire.com/news/home/20260129933836/en/Department-of-Defense-Awards-Genomind-Contract-for-Pharmacogenomics-Consulting

#

Genomind awarded DoD contract to advance pharmacogenomics, embedding genetic insights into military health records to improve care and readiness.

01/27/2026

Medications and mental health decisions are complex, and too often, patients are left to navigate these decisions through trial-and-error.

Genomind is here to bring clarity by giving you personalized, actionable genetics-based insights so that you can better understand how your genes may influence medication response and mental health.

Take the next step towards more personalized, targeted care: https://genomind.com/who-we-support/individuals/

Your genes tell your unique story—Genomind helps you turn the page to better health with PGx and MentalHealthMap™.

01/23/2026

After years of trial and error, Kalie finally found out why the medications she was taking weren't work, and was about to switch to medications that actually help.

Every day, patients like Kalie are using Genomind's PGx test to gain clarity about how their bodies respond to medications and find options that actually help.

Personalized, genetics-based insights matter and can change everything. Get started today: https://genomind.com/solutions/genomind-pgx-test/

01/21/2026

What does a test tell you?

01/19/2026

On this Martin Luther King Jr. Day, we reflect on the lasting impact of Dr. King's life, work, and service.

At Genomind, we believe that everyone can be great, and that greatness shows up in service of better care. We are committed in supporting providers and patients reduce trial-and-error and support more personalized, equitable care with our tests so that they can focus on what truly matters: better outcomes and better health.